728 related articles for article (PubMed ID: 11156958)
1. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.
Kasahara Y; Tuder RM; Taraseviciene-Stewart L; Le Cras TD; Abman S; Hirth PK; Waltenberger J; Voelkel NF
J Clin Invest; 2000 Dec; 106(11):1311-9. PubMed ID: 11104784
[TBL] [Abstract][Full Text] [Related]
3. Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.
Voelkel NF; Cool C; Taraceviene-Stewart L; Geraci MW; Yeager M; Bull T; Kasper M; Tuder RM
Crit Care Med; 2002 May; 30(5 Suppl):S251-6. PubMed ID: 12004244
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
5. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
[TBL] [Abstract][Full Text] [Related]
6. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
Sakao S; Tatsumi K
Respiration; 2011; 81(3):253-61. PubMed ID: 21116108
[TBL] [Abstract][Full Text] [Related]
7. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells.
Sakao S; Taraseviciene-Stewart L; Lee JD; Wood K; Cool CD; Voelkel NF
FASEB J; 2005 Jul; 19(9):1178-80. PubMed ID: 15897232
[TBL] [Abstract][Full Text] [Related]
8. A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.
Taraseviciene-Stewart L; Gera L; Hirth P; Voelkel NF; Tuder RM; Stewart JM
Can J Physiol Pharmacol; 2002 Apr; 80(4):269-74. PubMed ID: 12025960
[TBL] [Abstract][Full Text] [Related]
9. Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Derrett-Smith EC; Dooley A; Gilbane AJ; Trinder SL; Khan K; Baliga R; Holmes AM; Hobbs AJ; Abraham D; Denton CP
Arthritis Rheum; 2013 Nov; 65(11):2928-39. PubMed ID: 23839959
[TBL] [Abstract][Full Text] [Related]
10. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.
Le Cras TD; Markham NE; Tuder RM; Voelkel NF; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2002 Sep; 283(3):L555-62. PubMed ID: 12169575
[TBL] [Abstract][Full Text] [Related]
11. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
[TBL] [Abstract][Full Text] [Related]
13. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
[TBL] [Abstract][Full Text] [Related]
14. The pathobiology of pulmonary hypertension. Endothelium.
Tuder RM; Cool CD; Yeager M; Taraseviciene-Stewart L; Bull TM; Voelkel NF
Clin Chest Med; 2001 Sep; 22(3):405-18. PubMed ID: 11590837
[TBL] [Abstract][Full Text] [Related]
15. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
Fong TA; Shawver LK; Sun L; Tang C; App H; Powell TJ; Kim YH; Schreck R; Wang X; Risau W; Ullrich A; Hirth KP; McMahon G
Cancer Res; 1999 Jan; 59(1):99-106. PubMed ID: 9892193
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.
Shaheen RM; Tseng WW; Davis DW; Liu W; Reinmuth N; Vellagas R; Wieczorek AA; Ogura Y; McConkey DJ; Drazan KE; Bucana CD; McMahon G; Ellis LM
Cancer Res; 2001 Feb; 61(4):1464-8. PubMed ID: 11245452
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
[TBL] [Abstract][Full Text] [Related]
18. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]